Merck Says Cholesterol Drug Failed To Show Benefit

Drugmaker Merck & Co. says it will not seek U.S. approval for its cholesterol drug Tredaptive and is recommending doctors abroad stop prescribing it to new patients, based on failed study results.

Topics:  drugmaker merck    co   u.s    tredaptive   failed   cholesterol drug   
BING NEWS:
  • Why a ‘nice guy’ former drug addict is Netflix’s new king of comedy
    There’s something uncanny about coming face to face with someone you only know as a comedy character: like if you actually met Bill Cosby’s childhood friend Fat Albert, or David Sedaris’s sister ...
    05/3/2024 - 4:00 am | View Link
  • Why Women are Less Likely to be Prescribed Cholesterol Medications Such as Statins
    Researchers say women with heart disease are less likely to be prescribed cholesterol-lowering medications such as statins than men with the same conditions ...
    04/25/2024 - 10:05 pm | View Link
  • What is high cholesterol and can statin drugs help? Here are 3 things to know
    There can be a genetic link for high cholesterol, but for the majority of us, lifestyle and diet will be the key deciding factors in how high it goes.
    04/24/2024 - 10:01 pm | View Link
  • Merck axes cholesterol drug despite phase 3 success
    Merck & Co has said it will not file its cholesterol drug anacetrapib with regulators, saying that trial results are not good enough for clinical filings. The news came in a brief statement ...
    10/11/2017 - 1:00 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News